CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi(Tabriz University of Medical Sciences), Farhad Motavalli Khiavi(Pasteur Institute of Iran), В. А. Сафонов(All-Russian Scientific Research Veterinary Institute of Pathology, Pharmacology and Therapy), Sepideh Izadi(German Cancer Research Center), Roza Motavalli(Tabriz University of Medical Sciences), Safa Tahmasebi(Shahid Beheshti University of Medical Sciences), Naghmeh Shirafkan(German Cancer Research Center), Yashwant Pathak(University of South Florida), Lakshmi Thangavelu(Saveetha University), Mostafa Jarahian(Tabriz University of Medical Sciences), Max Stanley Chartrand, Ali Hassanzadeh(German Cancer Research Center), Alexei Valerievich Yumashev(Sechenov University), Markov Alexander(Tyumen State Medical University), Navid Shomali(German Cancer Research Center)
Cited by 573
Related Papers
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
RETRACTED ARTICLE: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
|Journal of Translational Medicine|2021|204
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
|Stem Cell Research & Therapy|2021|132
Targeting STAT3 in cancer and autoimmune diseases
|European Journal of Pharmacology|2020|110
Surface Modification of Metallic Nanoparticles for Targeting Drugs
|Coatings|2023|109